Topics

Articles

Balancing innovation focus with optimized decision-making.


Biotech’s Achilles’ Heel

Investigators evaluate differences in end-of-life care between Medicare beneficiaries in Medicare Advantage vs. traditional Medicare. 

Does Medicare Properly Cover End-of-Life Care for All Beneficiaries? 

How teamwork among safety-net healthcare providers and pharma can make the difference. 

Improving Cross-Industry Collaboration on Drug Discount Programs 

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time. 

Determining Drug Development Costs in the United States

A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.

The Association Between 340B Program Involvement and Availability of Hospital Services

Podcasts

Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.

Navigating Market Access Hurdles

Videos

In this Pharmaceutical Commerce video interview, Blake Powers, CEO of Medigi, explains how digital formats help manufacturers better manage price based on real-time data, along with the impact of NDC-specific price dexterity.

Helping Manufacturers Better Manage Price

In this Pharmaceutical Commerce video interview, Blake Powers, CEO of Medigi,  discusses his first byline with the publication, along with why the industry may be stuck in its ways in certain aspects.

Exploring the Concept of Dynamic Pricing 

The impact of income-based price controls in healthcare. 

Justifying Price Fairness

An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.
